de Verneuil Vanina sold VIR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001628280-26-070025

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 3, 2026

Published

Nov 4, 2026

Ingested by INSIDER

Nov 4, 22:39 UTC

Last re-read

Nov 5, 18:10 UTC

Extracted facts

Filer

de Verneuil Vanina

Role

EVP, General Counsel, Corp Sec

Transaction

Open-market saleAs filed: “S”

Asset

Vir Biotechnology, Inc.

Ticker

VIR

Shares

2,407

Price per share

$11.1

Value

$26,718

Execution date (reported)

Nov 3, 2026

Owned after transaction

110.2K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

1

Calculation

What this establishes

de Verneuil Vanina filed this Form 4 reporting a open-market sale of VIR on Nov 3, 2026. It became public on Nov 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP, General Counsel, Corp Sec

de Verneuil Vaninacik:0002036234

Issuer

Vir Biotechnology, Inc.cik:0001706431

Revision history · 0

No field has changed since this record was first ingested.